微博
加入微博一起分享新鲜事
登录
|
注册
140
Adjuvant Therapy Combining Donafenib and Sintilimab Enhances Recurrence-Free Survival in Hepatocellular Carcinoma Patients With High-Risk Recurrence Factors After Radical Resection: A Retrospective Cohort Study https://journal.hep.com.cn/medcommoncology/EN/10.1002/mog2.70013
请登录并选择要私信的好友
300
Adjuvant Therapy Combining Donafenib and Sintilimab Enhances Recurrence-Free Survival in Hepatocellular Carcinoma Patients With High-Risk Recurrence Factors After Radical Resection: A Retrospective Cohort Study https://journal.hep.com.cn/medcommoncology/EN/10.1002/mog2.70013
赞一下这个内容
公开
分享
获取分享按钮
正在发布微博，请稍候